Previous results from our laboratory have indicated that small intravenous doses of the u2-adrenergic agonist clonidine increase serotonin (5-HT) neurotransmission by attenuating the release of endogenous norepinephrine (NE), as a result of the activation of u2-adrenergic autoreceptor on NE neurons, and that high doses of clonidine decrease 5-HT neurotransmission by directly activating u2-adrenergic heteroreceptors on 5-HT terminals. The aim of the present study was to assess whether antidepressant treatments that increase the synaptic concentration of NE or 5-HT alter the ability of clonidine to modulate 5-HT neurotransmission through these two u2-adrenoceptors. Rats were treated for 3 weeks with 0.75 mglkg per day of befloxatone (a reversible inhibitor of monoamine oxidase A), 10 mglkg per day of ni soxetine (a selective NE reuptake inhibitor), 10 mglkg per day of paroxetine (a selective 5-HT reuptake inhibitor)
or saline using subcutaneous osmotic minipumps (removed 48 hours before the experiment). No significant change in the effect of the small dose of clonidine (10 Jjglkg, IV) was found following the befloxatone, the nisoxetine, or the paroxetine treatments. The reduction of 5-HT neurotransmission by the high dose of clonidine (400 Jjglkg, IV) was no longer present in rats treated with nisoxetine or befloxatone, but was unaltered in those treated with paroxetine. Furthermore, in rats pretreated with the NE neurotoxin 6-hydroxydopamine, a long-term treatment with befloxatone failed to alter the reducing effect of the high dose of clonidine but abolished the reducing effect of the low dose of clonidine. These results suggest that antidepressant drugs that increase NE synaptic concentration induce a desensitization of u2-heteroreceptor on 5-HT terminals.
[Neuropsychopharmacology 10: [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] 1994] Several studies have documented the possibility that presynaptic u2-adrenergic autoreceptors become desen sitized following long-term antidepressant treatments that increase the synaptic concentration of norepineph rine (NE) (Crews and Smith 1978; Svensson and Usdin 1978; McMillen et al. 1980; Spyraky and Fibiger 1980; Cohen et al. 1982; Finberg and Tal 1985; Lacroix et al. 1991) . Furthermore, the density of high-affinity state u2-adrenoceptors has been shown to be increased on platelets of depressed patients, a condition normalized by long-term treatment with antidepressant drugs (Garcia-Sevilla et al. 1986 Doyle et al. 1985; Takeda et al. 1989; Piletz et al. 1991) . However, not all antidepressant treatments share the property of de creasing these u2-adrenoceptors (Willner 1985) . In con trast, several classes of antidepressant treatments have been shown to alter serotonin (5-HT) neurotransmis sion (for review, see Blier et aI., 1990) .
The capacity of u2-adrenergic ligands to modulate the evoked release of [ 3 H]5-HT in vitro has long been known to be exerted by u2-adrenoceptors located on 5-HT terminals (Starke and Monte11973; Gothert and Huth 1980; Mulder 1980,1982; Goth ert et al. 1981; Maura et al. 1982) . Using an in vivo elec trophysiologic paradigm, it was recently shown that these u2-adrenergic heteroreceptors in the rat hip pocampus are tonically activated by endogenous NE (Mongeau et al. 1993) , as is the case in the human brain (Galzin et al. 1992; Feuerstein et al. 1993) . Small doses (2 �g/kg and 10 �g/kg IV) of the u2-adrenergic agonist clonidine enhance 5-HT neurotransmission, an effect that is abolished by a 6-hydroxydopamine (6-0HDA) pretreatment and blocked by the u2-adrenergic an tagonist yohimbine (0.1 mg/kg IV). These results indi cate that a low dose of clonidine preferentially activates u2-adrenergic autoreceptors on NE neurons, reducing the tonic inhibitory action of endogenous NE on U2-adrenergic heteroreceptors on 5-HT terminals and, con sequently, increasing 5-HT release. However, at higher doses (100 �g/kg and 400 �g/kg IV), clonidine decreases 5-HT neurotransmission through a direct activation of u2-adrenergic heteroreceptors, as this effect is not affected by NE denervation and is blocked by yohim bine (1 mg/kg IV; Mongeau �t al. 1993) .
In the present study, this in vivo modulation of 5-HT neurotransmission by clonidine via u2-adrenergic auto and heteroreceptors was used to investigate the effect of long-term treatments that increase the synaptic con centration of NE or 5-HT. The changes in the synaptic concentration of the neurotransmitters were induced by either selective reuptake blockade or monoamine ox idase A (MAO-A) inhibition. This electrophysiologic paradigm was considered most appropriate to inves tigate the modulation of 5-HT neurotransmission by the NE system because, as described before, it allows the in vivo assessment of the responsiveness of the U2-adrenergic heteroreceptors on 5-HT terminals and of the level of tonic inhibitory action of NE acting on them.
METHODS

Animals and Treatments
Male Sprague-Dawley rats, maintained on a 12-hour/12-hour light-dark cycle with free access to food and wa ter, were treated over a course of 3 weeks with 0.75 mg/kg per day of the reversible MAO-A inhibitor beflox-NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO. 1 atone (Curet et al. 1992a) , 10 mg/kg per day of the selec tive 5-HT reuptake inhibitor paroxetine (Thomas et al. 1987) , 10 mg/kg per day of the selective NE reuptake inhibitor nisoxetine (Fuller et al. 1979) , or saline deliv ered by osmotic minipumps (ALZA, Palo Alto, CAl in serted subcutaneously. The minipumps were removed 48 hours before the experiments began to allow elimi nation of the drugs. Lesions of NE neurons were per formed under chloral hydrate anesthesia (400 mg/kg IP) by injecting 6-0HDA intracerebroventricularly (120 �g free base in 20 �l of 0.9% N aCl and 0.1 % ascorbic acid) 1 hour after an injection of fluoxetine (10 mg/kg, IP) administered to protect the 5-HT system from the neurotoxic action of 6-0HDA. One week after this pro cedure, the rats were treated with 0.75 mg/kg per day of befloxatone for 3 weeks. At the time of the experi ments, the rats (weighing between 325 and 375 g) were anesthetized with an injection of 400 mg/kg (IP) of chlo ral hydrate.
Recording from Dorsal Hippocampus CA3
Pyramidal Neurons
Extracellular unitary recording and microiontophore sis onto pyramidal neurons in the CA3 region of the dorsal hippocampus were conducted with five-barrelled micropipettes, pulled conventionally with the tip bro ken to a diameter of 9 �m to 11 �m. The central barrel, used for recording, was tilled with a 2 moliL NaCl so lution. The side barrels contained the following solu tions: 5-HT creatinine sulfate (0.5 mmoliL in 200 rnrnoliL NaCl, pH 4), NE bitartrate (20 mmollL in 200 mmoliL NaCl, pH 4), acetylcholine chloride (20 mmol/L in 200 mmoliL NaCl, pH 4), and a 2-moliL NaCl solution used for automatic current balancing. The 5-HT and NE so lutions were retained with a -7 nA current between ejections. Pyramidal neurons were identified by their large amplitude (0.5 mV to 1.2 mV) and long-duration (0.8 msec to 1. 2 msec) simple spikes alternating with complex spike discharges (Kandel and Spencer 1961) . These characteristics readily allow the differentiation of pyramidal neurons from interneurons. A small cur rent or leak of acetylcholine (-1 nA to 5 nA) was used to activate silent or slowly discharging pyramidal neu rons to a physiologic firing rate (8 Hz to 12 Hz), because most of these cells do not discharge spontaneously in chloral hydrate-anesthetized rats. The responsiveness to micro iontophoretic application of 5-HT and NE was evaluated from the number of spikes suppressed/nA calculated by an on-line computer with a lOa-milli second discrimination.
To evaluate the effectiveness of the 6-0HDA lesion, the recovery of the fIring activIty of the pyramidal neu rons following the microiontophoretic application of NE was assessed by determining the recovery time 50 (RTso). This parameter is defined by the time (in sec onds) required for the firing rate to recover by 50% from the termination of the microiontophoretic application (de Montigny et al. 1980 ).
Stimulation of the 5-HT Pathway
To activate the 5-HT projections to the dorsal hip pocampus, a bipolar electrode (NE-I00; David Kopf, Tu junga, CA) was implanted on the midline with a 100 backward angle in the ventromedial tegmentum, 1 mm anterior to lambda, and 8.3 mm below the cortical sur face. Two hundreds square pulses of 0.5 milliseconds were delivered by a stimulator (Model 58800; Grass, Quincy, MA) at a frequency of 1 Hz and at an intensity of 300 J.l.A. The stimulation pulses and the firing activ ity of the neuron recorded were fed to a computer equipped with a Tecmar interface. Peristimulus time histograms were generated to determine the duration of suppression of firing, measured to absolute silence value (SIL, in milliseconds; Chaput et al. 1986 ). This parameter is obtained by dividing the total number of events suppressed with the stimulation by the mean frequency of firing of the neuron recorded. It thus represents an estimate of the duration of the suppres sion of firing corrected for the mean prestimulation frring frequency. Several lines of evidence indicate that the effect of the electrical stimulation of the ascending 5-HT pathway is due to the release of 5-HT into the syn aptic cleft. First, it is virtually abolished by a pretreat ment with the 5-HT neurotoxin 5,7-dihydroxytrypta mine de Montigny 1983, 1985) . Second, it is blocked by the acute intravenous injection of the 5-HT1A receptor antagonist BMY 7378 (Yocca et al. 1987; Chaput and de Montigny 1988) . Third, it is en hanced by terminal 5-HT autoreceptor blockade (Chaput et al. 1986 ). Fourth, it is reduced by terminal 5-HT autoreceptor activation .
In most neurons, following the suppression of firing induced by the electrical stimulation there is a transient increase of the probability of firing, the exact nature of which is presently unknown. However, this transient increase was shown to be unaffected by 5-HT reuptake inhibitors or MAO inhibitors (Blier et al. 1988 ). The rel ative activation was calculated by dividing the total number of supplementary events by the mean pres tim ulation firing frequency.
The effect of stimulating the ascending 5-HT fibers was determined while recording from the same neu ron before and after the successive intravenous injec tions of 10 J.l.g/kg and 400 J.l.g/kg of clonidine. The time elapsed between the control stimulation periods and those following the administration of clonidine was ap pro ximately 15 minutes.
Desensitization of u2-Adrenergic Heteroreceptors 43
Drugs
The following drugs were used: befloxatone (Dela lande, Rueil-Malmaison, France); paroxetine (Smith Kline Beecham, Harlow, England); nisoxetine and fluoxetine (Eli Lilly, Indianapolis, IN); clonidine HCl, 5-HT creatinine sulfate, NE bitartrate, 6-0HDA HCl, and acetylcholine chloride (Sigma Chemical, St. Louis, MO); and chloral hydrate (American Chemicals, Mon treal, Quebec, Canada).
Statistical Analyses
All results are expressed as means plus/minus standard error of the mean. The statistical significance of the difference between the effects of the stimulation of the 5-HT pathway before and after the administration of a drug in the same rat was assessed using the paired Student's t-test. Possible differences in the magnitude of the effects of clonidine between saline-and drug treated rats were tested for statistical significance by covariance analysis. Differences in the efficacy of the stimulation of the 5-HT pathway and neuronal respon siveness to microiontophoretic application of NE and 5-HT between saline-and drug-treated rats were as sessed for statistical significance using the unpaired Stu dent's t-test.
RESULTS
Effect of Long-Term MAO Inhibition on the
Modulation of 5-HT Neurotransmission by Clonidine
The suppressant effect of the electrical stimulation of the ascending 5-HT pathway on the firing rate of CA3 pyramidal neurons of the dorsal hippocampus was as sessed following long-term drug treatments. The peri stimulus time histograms in Figure lA show that 10 J.l.g/ kg IV of clonidine enhanced, while 400 J.l.g/kg IV re duced, the duration of suppression of firing in the same neuron of a saline-treated rat. Following the adminis tration of 10 J.l.g/kg and 400 J.l.g/kg IV of clonidine, the mean duration of suppression of firing of the saline treated group (Fig. IB) was increased by 37% ± 8% and decreased by 25% ± 7%, respectively. These incremen tal and decremental effects of clonidine were statisti cally significant at p < .01 and p < .001, respectively, using the paired Student's t-test. In contrast, the facilita tory effect on the firing rate of pyramidal neurons in duced by the electrical stimulation was not significantly changed by either dose of clonidine (Table 1) .
To induce a sustained increase in the synaptic con centration of 5-HT and NE, MAO-A was blocked over a 3-week period with 0.75 mg/kg per day of befloxa tone. The minipumps were removed 48 hours before Histograms showing the effects of the high and the low dose of c10nidine in saline-treated rats. The number of neurons tested is given at the bottom of the open column. * p < .01, ** P < .001, using a two-tailed paired Student's t-test, comparing prior to and following c10nidine administration. No. of Neurons 11 9 6 9 8
e Data are expressed as the relative activation in milliseconds ± the standard error of the mean.
d One-hundred twenty micrograms free base of 6-0HDA was injected intracerebroventricularly 1 week before the initiation of the befloxatone treatment. the experiments began to regain full enzymatic activity (Curet et al. 1992a ). The results in Figure 2A are repre se ntative peristimulus time histograms of the effect of c10nidine in befloxatone-treated rats. The small dose of c10nidine (10 J..L g/kg IV) produced a 72% ± 21% increase of the duration of the suppression of frring in the befloxatone-treated group (Fig. 2B) . Although the am plitude of the effect of the small dose of clonidine ap peared greater than that of the saline group (37% ± 8%; Fig. IB) , the difference between the two groups did not reach statistical signifIcance using covariance analysis. The subsequent administration of the high dose of cloni dine (400 J..L g/kg IV) decreased the duration of suppres sion of bring (Fig. 2B) ; however, unlike the controls (Fig.  IB) , it was not reduced below the initial value. This de creased responsiveness of the Q2-adrenoceptors medi ating the effect of the high dose of clonidine was not accompanied by any change in the responsiveness of pyramidal neurons of the CA 3 region of hippocampus to microiontophoretic applications of 5-HT and NE. The suppressant effects of the microiontophoretic applica tions of 5-HT and NE on the nring rate of the pyrami dal cells after the befloxatone treatment (5-HT: 322 ± 37 spikes/nA, n = 13; NE: 407 ± 43 spikes/nA; n = 13) were not diff erent from those of the saline-treated group (5-HT: 376 ± 62 spikes/nA, n = 11; NE: 400 ± 71 spikes/nA, n = 11). The assumption that the increased synaptic con centration of NE, but not that of 5-HT, is responsible for the decrease in the responsiveness of the Q2-adreno ceptors mediating the effect of the high dose of cloni dine was assessed by investigating the effect of the same befloxatone treatment in NE-denervated rats. Intracere broventricular injections of the neurotoxin 6-0HDA (1 Il g lk g Figure 3 . Effect of long-term treatment with 0.75 mg/kg per day of befloxatone in NE-denervated rats. The intracerebroven tricular injection of 120 Jlg of 6-0HDA was given 1 week before the minipump containing the drug was installed. The minipumps were removed 48 hours before the experiment began. A: Neuronal recovery from the microiontophoretic application of NE in saline (SAL) and 6-0HDA + befloxatone-pretreated rats. The RTso value is the time required for the neuron to re cover its fIring activity by 50% from the end of the application. The number of neurons tested is given at the bottom of each column. Data are expressed as mean ± SEM. * P < .001, two-tailed Student's t-test comparing control and 6-0HDA pretreated rats. B: Histograms showing the effects of systemic injections of clonidine on the efficacy of the electrical stimula tion of the ascending 5-HT pathway after a long-term treatment with befloxatone in six 6-0HDA-pretreated rats. * p < .01, using a two-tailed paired Student's t-test, comparing prior to and following clonidine administration.
hour after a pretreatment with the 5-HT reuptake in hibitor fluoxetine) were performed 1 week before initi ating the befloxatone treatment. The effectiveness of the lesions was verifIed by assessing the RTso of the fIring rate of CA3 pyramidal neurons following the microiontophoretic application of NE. In keeping with the notion that intact NE fIbers are required for the NE reuptake process to allow a prompt recovery of the fIring activity of these neurons (de Montigny et al. 1980) , the marked increased (327%) in the RTso of 6-0HDA treated rats (Fig. 3A) confIrmed an adequate lesioning of the NE terminals (except in two rats that were ex cluded from statistical analyses). In these conditions, the enhancing effect of the small dose of clonidine (10 J.lg/kg IV) was completely abolished, as previously ob served (Mongeau et al. 1993 ). On the other hand, the decreasing effect of the high dose of clonidine (400 J.lg/kg IV) was still present and was even of a greater ampli tude than that in the saline group (saline: 25% ± 5%, n = 11; 6-0HDA: 39% ± 9%, n = 6; P = .06, using covar iance analysis).
The efficacy of the stimulation of the 5-HT pathway in the saline group was compared to those in the drug treated groups using the unpaired Student's t test. The duration of suppression of fIring in the 6-0HDA plus befloxatone group was increased by 71% (SIL values: saline 38 msec ± 3 msec, n = 11; 6-0HDA + befloxa tone 65 msec ± 7 msec, n = 6; P < .01; Figs. 1 and 3) . However, the befloxatone treatment did not by itself change the efficacy of the stimulation in suppressing the fIring activity of the pyramidal neurons ( Figs. 1 and  2) . It is noteworthy that in the two rats pretreated with 6-0HDA plus befloxatone for which the NE denerva tion failed (as indicated by the unchanged RTso), the increase in 5-HT transmission was not observed, and the effects of clonidine were similar to those observed for the befloxatone group (data not shown). Finally, none of the above treatments signiflcantly changed the late excitatory effect on the flring rate induced by the electrical stimulation (Table 1) .
Effect of Long-Term Monoamine Uptake Inhibition on the Modulation of 5-HT Neurotransmission by Clonidine
For two reasons, it was deemed crucial to test whether monoamine reuptake inhibitors could also affect the u2-adrenoceptors that modulate 5-HT transmission. First, selective 5-HT reuptake inhibitors have long been known to have antidepressant efficacy, and, second, 5-HT and NE reuptake inhibitors have been shown to increase the synaptic concentration of 5-HT and NE, respectively (L'Heureux et al. 1986; Bel and Artigas 1992; Curet et al. 1992b) . The effect of a sustained in crease in the synaptic concentration of either NE or 5-HT was investigated using speciftc reuptake inhibitors. Fol lowing long-term treatment with the selective 5-HT re uptake inhibitor paroxetine (10 mg/kg per day for 21 days), the effects of the low and the high dose of cloni dine on 5-HT transmission were unchanged. After the paroxetine treatment, the small dose of clonidine (10 J,lg/kg IV) increased the efficacy of the stimulation of the 5-HT pathway by 29% ± 9% whereas the high dose (400 J,lg/kg IV) decreased it by 25% ± 7% (Fig. 4A) .
In contrast, the 21-day treatment with the selective NE reuptake inhibitor nisoxetine (10 mg/kg per day) produced effects similar to those obtained in the befloxatone-treated rats. The small dose of clonidine produced a 30% ± 8% increase (Fig. 4B) , which was similar to that of the saline group (Fig. 18) . The subse quent administration of the high dose of clonidine de creased the duration of suppression of flring; however, it was not reduced below the initial value (Fig. 4B) . Fur thermore, as observed in the befloxatone group (Fig.  2B) , there was no change in the responsiveness of py ramidal neurons of the CA3 region of hippocampus to microiontophoretic applications of 5-HT and NE in the nisoxetine-treated rats. The suppressant effects of the micro iontophoretic applications of 5-HT and NE on the frring rate of the pyramidal neurons after the nisoxe tine treatment (5-HT: 332 ± 66 spikes/nA, n = 11; NE: 378 ± 71 spikes/nA, n = 11) were not different from those of the saline-treated group (5-HT: 376 ± 62 spikes/nA, n = 11; NE: 400 ± 71 spikes/nA, n = 11).
The paroxetine and nisoxetine treatments did not signiftcantIy modify the efficacy of the stimulation of the 5-HT pathway in suppressing the flring activity of pyramidal neurons of the dorsal hippocampus (Fig. 4) . In addition, the late excitatory effect of the stimulation . The number of rats tested is given in side the columns. * p < .05, ** P < .01 using a two-tailed paired Student's t-test, comparing prior to and following clonidine administration.
observed on these same neurons was not changed by these treatments (Table 1) .
DISCUSSION
The present electrophysiologic data show that long term treatment with pharmacologic agents that increase the synaptic concentration of NE, but not that of 5-HT, decrease the inhibitory action of a high dose of cloni dine (400 J.1g/kg IV) on5-HT neurotransmission and that the enhancing effect of a low dose of clonidine (10 J.1g/kg IV) is not affected by such treatments (Figs. 2, and 4B ). These changes observed in the befloxatone and the nisoxetine groups are most likely related to the sus tained increase in NE concentration in the synapse, be cause similar changes were not produced either by long term 5-HT reuptake blockade or by long-term MAO-A inhibition in NE-denervated rats (Figs. 3B and 4B) . None of the long-term treatments produced any signifIcant changes in the enhancing effect of the low dose of cloni dine (Figs. 2 and 4) . However, the lesion of the NE neu rons abolished, as expected, this enhancing effect of clonidine (Fig. 3B) .
In a previous study, the incremental and decremen tal effects of clonidine have been fully characterized using the present electrophysiologic paradigm (Mon geau et al. 1993 ). On the one hand, it was concluded that the reducing effect of the high dose of clonidine is most likely mediated by the activation of (12-adrener gic heteroreceptors on 5-HT terminals, which results in a decrease in the amount of 5-HT released per action potential. On the other hand, low doses of clonidine enhance the suppression of fIring by preferentially ac tivating (12-adrenergic autoreceptors, thereby reducing the concentration of endogenous NE tonically activat ing (12-adrenergic heteroreceptors on 5-HT terminals (Mongeau et al. 1993) . Thus, the present results sug gest that although the sensitivity of (12-adrenergic het eroreceptors is reduced by long-term treatment with nisoxetine and befloxatone, an inhibitory action of en dogenous NE on 5-HT neurotransmission still appears to be present.
The magnitude of the effect of the small dose of clonidine on 5-HT neurotransmission does not provide a direct estimate of the responsiveness of the (12-adrenergic autoreceptors, because its magnitude is also determined by the level of activation of (12-adrenergic heteroreceptors by endogenous NE. Thus, the un altered effect of the low dose of clonidine after these treatments is not an indication that the (12-adrenergic autoreceptors on the cell body and terminals of NE neu rons are normosensitive. Previous investigations per formed in our laboratory have shown that terminal (12-adrenergic autoreceptors are desensitized following a long-term treatment with the NE reuptake inhibitor NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO. 1 desipramine (Lacroix et al. 1991) . However, despite an attenuated responsiveness of the somatodendritic NE auto receptors of locus coeruleus neurons to clonidine following this treatment, a 10-J.1g/kg IV dose of cloni dine still substantially decreased (85% instead of 100%) the fIring rate of these neurons. It can thus be concluded that the desensitization of the (12-adrenergic autorecep tors would not hinder the enhancement of 5-HT neu rotransmission that results from a decrease in the syn aptic concentration of NE when these autoreceptors are activated by the 10-J.1g/kg IV dose of clonidine. In fact, a desensitization of (12-adrenergic auto receptors could even increase the inhibitory tone of NE on 5-HT neu rotransmission, because the synaptic concentration of NE is normally expected to be increased when the nega tive feedback autoregulation is decreased.
It is also interesting that the high dose of clonidine in both nisoxetine-and befloxatone-treated rats brought back the effectiveness of the stimulation to initial value (Figs. 2B and 4B) , suggesting that these receptors still possess residual capacity to modulate 5-HT release af ter the befloxatone or the nisoxetine treatment. The tonic inhibitory action of endogenous NE on the (12-adrenergic heteroreceptors at baseline was probably maximal because the high dose of clonidine merely re established the initial duration of suppression of fIring (Figs. 2B and 4B ).
These observations lead us to the following in terpretation: normally 5-HT neurotransmission is de creased in the presence of an increased NE output. Af ter long-term exposure to a high concentration of synaptic NE, there is a desensitization of (12-adrenergic heteroreceptors. Although the paradigm used in the present study does not provide clues about the cellular mechanisms involved, it might result from a decrease in the density of the receptors, a change in the coup ling of the receptors with their G proteins, or an altera tion in second messenger function. This desensitiza tion would hinder the tonic inhibitory action of the NE system on 5-HT neurotransmission, more so in the con dition of a high NE output.
No change in the efficacy of 5-HT neurotransrnission was observed with long-term treatment with befloxatone, paroxetine, or nisoxetine. However, in the 6-0HDA pretreated rats, the long-term befloxatone treatment signifIcantly increased the duration of suppression of fIring. This increase most likely resulted from the deple tion of the endogenous NE that would normally exert a tonic inhibitory action on 5-HT neurotransmission through (12-adrenergic heteroreceptors. Finally, the in crease in the magnitude of the effect of the high dose of clonidine in these rats was expected and is consis tent with our previous study (Mongeau et al. 1993) . It was most likely related to a supersensitivity of the (12-adrenergic heteroreceptors resulting from the NE depletion.
To our knowledge, no study has directly assessed the modulation of 5-HT neurotransmission by u2-adre nergic ligands following antidepressant treatments in an in vivo paradigm. Nevertheless, this has been pre viously investigated in in vitro studies. Some have failed to detect a reduction in the efficacy of u2-adrenergic heteroreceptors function following MAO inhibition of NE reuptake blockade. GroB et al. (1987) reported no change in the potency of clonidine to inhibit the elec trically evoked overflow of [3H]5-HT in preloaded rat brain cerebral cortex slices when superfusing through out the experiment 1 �M of the NE reuptake inhibitor viloxazine. This result suggested that short-term ex posure to an elevated synaptic concentration of NE does not desensitize u2-adrenergic heteroreceptors on 5-HT terminals. However, long-term NE reuptake blockade with desipramine or long-term MAO inhibition with MDL 72394 or pargyline has not been reported to change the ability of u2-adrenergic heteroreceptors to reduce the electrically induced release of [3H]5-HT in rat cortical and hippocampal slices (Schlicker et al. 1982; Schoffelmeer and Mulder 1982; Palfreyman et al. 1986 ). Finally, another study using rat brain synaptosomes re vealed that the attenuation of K + -stimulated release of PH]5-HT by clonidine was diminished following a long-term treatment with the irreversible MAO inhibi tor clorgyline but not by desipramine (Ellison and Campbell 1986 ). This effect of clorgyline was, however, attributable to a competition between clonidine and the increased NE in the biophase. Such a competition, how ever, cannot account for the decreased sensitivity of Q2-adrenergic heteroreceptors to the high dose of cloni dine observed in the present study after the befloxa tone treatment, because this drug is a reversible MAO inhibitor and the minipumps were removed 48 hours before the experiments. The method of administration of the drugs might explain the absence of desensitiza tion of u2-adrenergic heteroreceptors in the abovemen tioned studies. In the present study, the drugs were continuously delivered through osmotic minipumps in serted subcutaneously, whereas desipramine was ad ministered orally in the studies by Schlicker et al. (1982) and Ellison and Campbell (1986) and intraperitoneally in the study of Schoffelmeer and Mulder (1982) . The oral or intraperitoneal administration of desipramine in rats might not produce sustained reuptake blockade, considering the important frrst-pass hepatic metabolism and also the much faster catabolism of such drugs in rats than in humans.
In vitro studies performed in our laboratory using osmotic minipumps provided results consistent with the desensitization of u2-adrenergic heteroreceptors. Long-term treatment with minalcipran, a NE reuptake inhibitor, reduced the NE inhibition of the electrically induced release of [3H]5-HT in the rat hippocampus, whereas long-term treatment with befloxatone shifted Desensitization of u2-Adrenergic Heteroreceptors 49 the concentration-effect curve to the right of the U2-adrenergic agonist UK 14.304 on electrically induced release of [3H]5-HT in guinea pig hypothalamus slices (Blier and Bouchard 1992; Blier et al. 1993) . Hence, these results suggest that u2-adrenergic heteroreceptors are endowed with the capacity to become desensitized af ter a sustained increase in NE synaptic concentration.
Although the antidepressant property of befloxa tone has not yet been documented in humans, all po tent MAO-A inhibitors, specific or not, that bind irre versibly or not to the enzyme (clorgyline, phenelzine, tranylcypromine, moclobemide, brofaromine, and tol oxatone) increase 5-HT and NE synaptic concentration and are effective in major depression. Furthermore, minalcipran which, like nisoxetine, selectively blocks the reuptake of NE (Blier et al. 1993) , has been reported to be an effective antidepressant in humans (Macher et al. 1989; von Frenckell et al. 1990) . It is thus possible that the desensitization of u2-adrenergic heterorecep tors on 5-HT terminals contributes to the therapeutic action of these drugs.
